NCT07050433View on ClinicalTrials.gov

Correlate Biomarkers for the SYNERGY- 201 Study

RecruitingOBSERVATIONAL

Enrollment

48

Participants

Timeline

Start Date

August 7, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

October 31, 2026

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST

CXCR2 as a biomarker

CXCR2 biomarker expression will be measured in tumor and immune cell samples

Trial Locations (1)

27705

RECRUITING

Duke University, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

Prostate Cancer Foundation

OTHER

lead

Duke University

OTHER

NCT07050433 - Correlate Biomarkers for the SYNERGY- 201 Study | Biotech Hunter | Biotech Hunter